The American College of Radiology and the American Brachytherapy Society practice parameter for transperineal permanent brachytherapy of prostate cancer

被引:31
|
作者
Bittner, Nathan H. J. [1 ]
Orio, Peter F., III [2 ,3 ]
Merrick, Gregory S. [4 ]
Prestidge, Bradley R. [5 ]
Hartford, Alan Charles [6 ]
Rosenthal, Seth A. [7 ]
机构
[1] Tacoma Valley Radiat Oncol Ctr, Tacoma, WA USA
[2] Brigham & Womens Hosp, Dept Radiat Oncol, Lebanon, NH USA
[3] Dana Farber Brigham & Womens Canc Ctr, Weymouth, MA USA
[4] Wheeling Hosp Med Pk, Schliffer Canc Ctr, Wheeling, WV USA
[5] Bon Secours Canc Inst, Dept Radiat Oncol, Norfolk, VA USA
[6] Dartmouth Hitchcock Med Ctr, Lebanon, NH USA
[7] Sutter Radiat Oncol Ctr, Roseville Radiat Oncol, Roseville, CA USA
关键词
Prostate cancer; Brachytherapy; Quality assurance; Safety; Dosimetry; EXTERNAL-BEAM RADIATION; PHASE-III TRIAL; INTERSTITIAL BRACHYTHERAPY; ANDROGEN SUPPRESSION; BIOCHEMICAL FAILURE; INTEROBSERVER VARIABILITY; RADICAL PROSTATECTOMY; MULTICENTER ANALYSIS; SEED IMPLANTATION; DOSE PRESCRIPTION;
D O I
10.1016/j.brachy.2016.06.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transperineal permanent brachytherapy is a safe and effective treatment option for patients with organ-confined prostate cancer. Careful adherence to established brachytherapy standards has been shown to improve the likelihood of procedural success and reduce the incidence of treatment related morbidity. A collaborative effort of the American College of Radiology (ACR) and the American Brachytherapy Society (ABS) has produced practice parameters for LDR prostate brachytherapy. These practice parameters define the qualifications and responsibilities of all the involved personnel, including the radiation oncologist, physicist and dosimetrist. Factors with respect to patient selection and appropriate use of supplemental treatment modalities such as external beam radiation and androgen suppression therapy are discussed. Logistics with respect to the brachytherapy implant procedure, the importance of dosimetric guidelines, and attention to radiation safety procedures and documentation are presented. Adherence to these parameters can be part of ensuring quality and safety in a successful prostate brachytherapy program. (C) 2016 American Brachytherapy Society and American College of Radiology. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:59 / 67
页数:9
相关论文
共 50 条
  • [41] Focal Therapy for Prostate Cancer with Permanent Prostate Brachytherapy
    Moran, B.
    Tack, K.
    Keyes, K.
    Banghart, K.
    Braccioforte, M.
    [J]. MEDICAL PHYSICS, 2011, 38 (06)
  • [42] Permanent prostate brachytherapy for intermediate risk prostate cancer
    Frazier, AJ
    Keole, SR
    Forman, JD
    Cher, M
    Zuniga, C
    Rosemberg, S
    [J]. RADIOLOGY, 2002, 225 : 266 - 267
  • [43] An evaluation of gender diversity in the American Brachytherapy Society
    Lu, Diana J.
    Luu, Michael
    Yashar, Catheryn M.
    Klopp, Ann H.
    Kamrava, Mitchell
    [J]. BRACHYTHERAPY, 2019, 18 (06) : 835 - 840
  • [44] Permanent interstitial brachytherapy for locallized prostate cancer
    王国民
    [J]. 外科研究与新技术, 2005, (03) : 205 - 205
  • [45] Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer
    Gelblum, DY
    Potters, L
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (01): : 119 - 124
  • [46] Pulmonary seed migration after permanent transperineal prostate brachytherapy is relatively common
    Sarosdy, MF
    Wilkerson, M
    Uhler, M
    [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 282 - 282
  • [47] THREE-DIMENSIONAL IMAGING IN GYNECOLOGIC BRACHYTHERAPY: A SURVEY OF THE AMERICAN BRACHYTHERAPY SOCIETY
    Viswanathan, Akila N.
    Erickson, Beth A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (01): : 104 - 109
  • [48] The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma
    Simpson, E. Rand
    Gallie, Brenda
    Laperrierre, Normand
    Beiki-Ardakani, Akbar
    Kivela, Tero
    Raivio, Virpi
    Heikkonen, Jorma
    Desjardins, Laurence
    Dendale, Remi
    Mazal, Alexandro
    Bornfeld, Norbert
    Sauerwein, Wolfgang
    Flueehs, Dirk
    Brualla, Lorenzo
    Honavar, Santosh G.
    Reddy, Vijay Anand P.
    Suzuki, Shigenobu
    Murakami, Naoya
    Saakyan, Svetlana
    Valskiy, Vladimir
    Amiryan, Anush
    Seregard, Stefan
    All-Eriksson, Charlotta
    Hjelmqvist, Lars
    Lundell, Goran
    Sinclair, Georges
    Lundell, Marie
    Damato, Bertil
    Errington, R. Doug
    Mayles, Philip
    Mayles, Helen
    Bergstrom, Chris
    Grossniklaus, Hans
    Crocker, Ian
    Butker, Elizabeth
    Wilson, Matthew
    Haik, Barrett
    Geischen, Holger
    Patra, Pradeep
    Duker, Jay
    Mignano, John
    Rivard, Mark
    Finger, Paul T.
    Semenova, Ekaterina
    Choi, Walter
    Kalach, Nina I.
    [J]. BRACHYTHERAPY, 2014, 13 (01) : 1 - 14
  • [49] Brachytherapy for Patients With Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update
    Chin, Joseph
    Rumble, R. Bryan
    Kollmeier, Marisa
    Heath, Elisabeth
    Efstathiou, Jason
    Dorff, Tanya
    Berman, Barry
    Feifer, Andrew
    Jacques, Arthur
    Loblaw, D. Andrew
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (15) : 1737 - +
  • [50] The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumors
    Sharma, Navesh K.
    Kappadath, S. Cheenu
    Chuong, Michael
    Folkert, Michael
    Gibbs, Peter
    Jabbour, Salma K.
    Jeyarajah, D. Rohan
    Kennedy, Andrew
    Liu, David
    Meyer, Joshua E.
    Mikell, Justin
    Patel, Rahul S.
    Yang, Gary
    Mourtada, Firas
    [J]. BRACHYTHERAPY, 2022, 21 (05) : 569 - 591